Tag: cardionovum

High-grade evidence supports use of APERTO DCB in vascular access stenosis

Jos van den Berg (Lugano, Switzerland) tells Vascular News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of...

Registry shows better patency and fewer reinterventions for Aperto drug-coated balloon...

Drug-coated balloon treatment for vascular access stenosis offers a real alternative to plain balloon angioplasty, reducing the rate of reinterventions and prolonging the lifespan of...

A New DCB Era of Safety and Efficacy

In this supplement: -SAFEPAX: No drug coating pitfalls -Why the RAPID trial is of clinical importance for a paradigm shift -Vascular access rescue with...

LEG-DEB registry reports encouraging six-month interim analysis for LegFlow

Six-month interim analysis of the Legflow drug-eluting balloon for the treatment of femoropopliteal occlusions (LEG-DEB) registry indicates that “the use of a new generation...